Short Communication
|
Open Access
Featured
-
-
Clinical Study
| Open AccessMegestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
- N Penel
- , S Clisant
- & A Adenis
-
Molecular Diagnostics
| Open AccessExpansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery
- D D Fang
- , Y J Kim
- & P A Moore
-
Clinical Study
| Open AccessThe effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- R E Coleman
- , M C Winter
- & H Thorpe
-
Clinical Study
| Open AccessLong-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status
- D G R Evans
- , A Moran
- & F Lalloo
-
Short Communication
| Open AccessParticipants’ uptake of clinical trial results: a randomised experiment
- J Mancini
- , D Genre
- & C Julian-Reynier
-
-
Clinical Study
| Open AccessHealth-related quality of life in patients with metastatic renal cell carcinoma treated with sunitinib vs interferon-α in a phase III trial: final results and geographical analysis
- D Cella
- , M D Michaelson
- & R J Motzer
-
Clinical Study
| Open AccessCetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- F Lordick
- , B Luber
- & C Peschel
-
Clinical Study
| Open AccessPhase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
- T Trarbach
- , M Moehler
- & S Kanzler
-
Clinical Study
| Open AccessCholine and betaine intake and risk of breast cancer among post-menopausal women
- E Cho
- , M D Holmes
- & W C Willett